Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
UBS
Medtronic
Farmers Insurance
McKesson
AstraZeneca
US Army
Argus Health

Generated: November 21, 2018

DrugPatentWatch Database Preview

Flurbiprofen sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for flurbiprofen sodium and what is the scope of flurbiprofen sodium freedom to operate?

Flurbiprofen sodium is the generic ingredient in two branded drugs marketed by Bausch And Lomb and Allergan, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for flurbiprofen sodium. Five suppliers are listed for this compound.

Pharmacology for flurbiprofen sodium
Synonyms for flurbiprofen sodium
(1,1'-Biphenyl)-4-acetic acid, 2-fluoro-alpha-methyl-, sodium salt
2-Fluoro-alpha-methyl-4-diphenylacetic acid sodium salt
56767-76-1
8308AB
AF10211
AN-40130
AUAGTGKMTMVIKN-UHFFFAOYSA-M
C15H12FNaO2
CHEMBL1200990
EINECS 260-373-2
Flurbiprofen sodium [USAN]
Flurbiprofen sodium [USP]
Flurbiprofen sodium salt
KB-51899
LS-44096
Ocufen
RL04144
SCHEMBL4735171
sodium 2-(2-fluorobiphenyl-4-yl)propanoate
sodium 2-(3-fluoro-4-phenyl-phenyl)propanoate
Sodium 2-fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetate
Sodium 2-fluoro-alpha-methyl(1,1'-biphenyl)-4-acetate
Sodium 2-fluoro-alpha-methyl[1,1'-biphenyl]-4-acetate
Sodium 3-fluoro-4-phenylhydratropate
Sodium flurbiprofen
Sodiumflurbiprofen

US Patents and Regulatory Information for flurbiprofen sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb FLURBIPROFEN SODIUM flurbiprofen sodium SOLUTION/DROPS;OPHTHALMIC 074447-001 Jan 4, 1995 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Allergan OCUFEN flurbiprofen sodium SOLUTION/DROPS;OPHTHALMIC 019404-001 Dec 31, 1986 AT RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for flurbiprofen sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan OCUFEN flurbiprofen sodium SOLUTION/DROPS;OPHTHALMIC 019404-001 Dec 31, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan OCUFEN flurbiprofen sodium SOLUTION/DROPS;OPHTHALMIC 019404-001 Dec 31, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
UBS
Medtronic
Farmers Insurance
McKesson
AstraZeneca
US Army
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.